Search Results - "Hunault, Mathilde"

Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Authors: Laloi, Louise Billotey, Natacha Chaumard Dumas, Pierre‐Yves et al.

Source: Cancer Medicine. Mar2023, Vol. 12 Issue 6, p7175-7181. 7p.

Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.

Authors: Boudry, Augustin Darmon, Sasha Duployez, Nicolas et al.

Source: BMC Bioinformatics. 12/9/2022, Vol. 23 Issue 1, p1-2. 2p.

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML.

Authors: Gyan, Emmanuel Pigneux, Arnaud Hunault, Mathilde et al.

Source: Scientific Reports. 6/13/2022, Vol. 12 Issue 1, p1-9. 9p.

New insights in the treatment of patients with solitary bone plasmacytoma.

Authors: Mheidly, Kayane Lamy De La Chapelle, Thierry Hunault, Mathilde et al.

Source: Leukemia & Lymphoma. Nov2019, Vol. 60 Issue 11, p2810-2813. 4p.

Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.

Authors: Lacombe, Valentin Nunes Gomes, Christopher Robin, Jean‐Baptiste et al.

Source: European Journal of Haematology. Oct2021, Vol. 107 Issue 4, p489-496. 8p.

Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.

Authors: Boudry, Augustin Darmon, Sasha Duployez, Nicolas et al.

Source: BMC Bioinformatics. 10/28/2022, Vol. 23 Issue 1, p1-16. 16p.

Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide.

Authors: Jullien, Maxime Orvain, Corentin Berceanu, Ana et al.

Source: Cancer Medicine. Oct2021, Vol. 10 Issue 20, p7194-7202. 9p.

Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.

Authors: Jouzier, Claire Hamel, Jean‐François Dumas, Pierre‐Yves et al.

Source: European Journal of Haematology. Jun2021, Vol. 106 Issue 6, p859-867. 9p.

Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.

Authors: Hormi, Myriam Birsen, Rudy Belhadj, Maya et al.

Source: European Journal of Haematology. Nov2020, Vol. 105 Issue 5, p588-596. 9p.

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.

Authors: Brousseau, Maud Parot-Schinkel, Elsa Moles, Marie-Pierre et al.

Source: Histopathology. May2010, Vol. 56 Issue 6, p758-767. 10p. 2 Color Photographs, 1 Black and White Photograph, 4 Charts.

Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase.

Authors: Mollard, Lise-Marie Chauveau, Aurélie Boyer-Perrard, Françoise et al.

Source: Leukemia & Lymphoma. Dec2018, Vol. 59 Issue 12, p2812-2820. 9p.

CAR-T "the living drugs", immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy.

Authors: Liu, Delong^1,2 (AUTHOR) Delong_liu@nymc.edu

Source: Journal of Hematology & Oncology. 11/8/2019, Vol. 12 Issue 1, pN.PAG-N.PAG. 1p.